These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 13597288)

  • 41. Development in anticoagulant therapy.
    van Doormaal FF; Büller HR; Middeldorp S
    Crit Rev Oncol Hematol; 2008 May; 66(2):145-54. PubMed ID: 18032061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hemostasis and blood coagulation revisited: mechanisms and therapeutic implications].
    Hermans C; Deneys V
    J Pharm Belg; 2004; 59(1):15-26. PubMed ID: 15129576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Protamin tolerance test as a modification of the heparin tolerance test and of protamin titration].
    BELLER FK; STEICHELE D
    Z Gesamte Exp Med; 1957; 128(5):458-70. PubMed ID: 13456692
    [No Abstract]   [Full Text] [Related]  

  • 44. The effects of glycosaminoglycans on coagulation: a thromboelastographic study.
    Senzolo M; Coppell J; Cholongitas E; Riddell A; Triantos CK; Perry D; Burroughs AK
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):227-36. PubMed ID: 17413758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.
    Wang ZM; Li L; Li B; Guo SY
    Yao Xue Xue Bao; 2006 Apr; 41(4):323-7. PubMed ID: 16856476
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Histamine-liberating substances; their importance in the dermatological field].
    CACCIALANZA P
    Minerva Dermatol; 1959 Jan; 34(1):10-3. PubMed ID: 13643814
    [No Abstract]   [Full Text] [Related]  

  • 47. Partition of blood histamine before and after clotting in health and disease states.
    VALENTINE WN; LAWRENCE JS
    Am J Med Sci; 1948 Dec; 216(6):619-24. PubMed ID: 18103247
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of heacrin in degenerative inflammatory and further peripheral circulatory disorders and other diseases].
    SZIRMAI E
    Yokohama Med Bull; 1957 Jun; 8(3):201-8. PubMed ID: 13507408
    [No Abstract]   [Full Text] [Related]  

  • 49. [Discharge of heparin in the dog treated by sinomenine].
    BINET L; QUIVY D
    C R Hebd Seances Acad Sci; 1957 Mar; 244(12):1579-82. PubMed ID: 13427225
    [No Abstract]   [Full Text] [Related]  

  • 50. [Histamine-liberating properties of O-hydroxyethylated derivatives of rutoside in the dog].
    Lecomte J
    C R Seances Soc Biol Fil; 1970; 164(5):1163-5. PubMed ID: 4250659
    [No Abstract]   [Full Text] [Related]  

  • 51. Liberating data: the WHO response.
    Chestnov O; Riley L; Bettcher DW
    Lancet Diabetes Endocrinol; 2016 Aug; 4(8):648. PubMed ID: 27318673
    [No Abstract]   [Full Text] [Related]  

  • 52. [Do anti-inflammatory agents modify verified hypocoagulability in dogs during various shocks liberating histamine or heparin].
    BINET L; QUIVY D
    C R Seances Soc Biol Fil; 1958; 152(3):419-21. PubMed ID: 13597288
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.